These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31354891)

  • 1. Metabolic Disturbances Identified in Plasma Samples from ST-Segment Elevation Myocardial Infarction Patients.
    Goulart VAM; Santos AK; Sandrim VC; Batista JM; Pinto MCX; Cameron LC; Resende RR
    Dis Markers; 2019; 2019():7676189. PubMed ID: 31354891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum metabolite profiling of ST-segment elevation myocardial infarction using liquid chromatography quadrupole time-of-flight mass spectrometry.
    Gundogdu G; Senol O; Demirkaya Miloglu F; Koza Y; Gundogdu F; Hacımüftüoğlu A; Abd El-Aty AM
    Biomed Chromatogr; 2020 Feb; 34(2):e4738. PubMed ID: 31677392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma Metabolic Profile Determination in Young ST-segment Elevation Myocardial Infarction Patients with Ischemia and Reperfusion: Ultra-performance Liquid Chromatography and Mass Spectrometry for Pathway Analysis.
    Huang L; Li T; Liu YW; Zhang L; Dong ZH; Liu SY; Gao YT
    Chin Med J (Engl); 2016 May; 129(9):1078-86. PubMed ID: 27098794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in concentrations of circulating fibroblast activation protein alpha are associated with myocardial damage in patients with acute ST-elevation MI.
    Tillmanns J; Fraccarollo D; Galuppo P; Wollert KC; Bauersachs J
    Int J Cardiol; 2017 Apr; 232():155-159. PubMed ID: 28082091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparative Metabolomics Approach Reveals Early Biomarkers for Metabolic Response to Acute Myocardial Infarction.
    Ali SE; Farag MA; Holvoet P; Hanafi RS; Gad MZ
    Sci Rep; 2016 Nov; 6():36359. PubMed ID: 27821850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Plasma Metabolomics Implicates Modified 9-cis-Retinoic Acid in the Phenotype of Left Main Artery Lesions in Acute ST-Segment Elevated Myocardial Infarction.
    Huang L; Zhang L; Li T; Liu YW; Wang Y; Liu BJ
    Sci Rep; 2018 Aug; 8(1):12958. PubMed ID: 30154509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating HtrA2 as a novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury in ST-segment elevation myocardial infarction.
    Hortmann M; Robinson S; Mohr M; Haenel D; Mauler M; Stallmann D; Reinoehl J; Duerschmied D; Peter K; Bode C; Ahrens I
    Int J Cardiol; 2017 Sep; 243():485-491. PubMed ID: 28602551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local Matrix Metalloproteinase 9 Level Determines Early Clinical Presentation of ST-Segment-Elevation Myocardial Infarction.
    Nishiguchi T; Tanaka A; Taruya A; Emori H; Ozaki Y; Orii M; Shiono Y; Shimamura K; Kameyama T; Yamano T; Yamaguchi T; Matsuo Y; Ino Y; Kubo T; Hozumi T; Hayashi Y; Akasaka T
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2460-2467. PubMed ID: 27687605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR-proADM as a Prognostic Marker in Patients With ST-Segment-Elevation Myocardial Infarction-DANAMI-3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy.
    Falkentoft AC; Rørth R; Iversen K; Høfsten DE; Kelbæk H; Holmvang L; Frydland M; Schoos MM; Helqvist S; Axelsson A; Clemmensen P; Jørgensen E; Saunamäki K; Tilsted HH; Pedersen F; Torp-Pedersen C; Kofoed KF; Goetze JP; Engstrøm T; Køber L
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29776961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort.
    Miyachi H; Takagi A; Miyauchi K; Yamasaki M; Tanaka H; Yoshikawa M; Saji M; Suzuki M; Yamamoto T; Shimizu W; Nagao K; Takayama M
    Heart Vessels; 2016 Nov; 31(11):1740-1751. PubMed ID: 26758733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics, Management, and Outcome of Transient ST-elevation Versus Persistent ST-elevation and Non-ST-elevation Myocardial Infarction.
    Blondheim DS; Kleiner-Shochat M; Asif A; Kazatsker M; Frimerman A; Abu-Fanne R; Neiman E; Barel M; Levy Y; Amsalem N; Shotan A; Meisel SR
    Am J Cardiol; 2018 Jun; 121(12):1449-1455. PubMed ID: 29699746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in Short- and Long-Term Outcomes Among Older Patients With ST-Elevation Versus Non-ST-Elevation Myocardial Infarction With Angiographically Proven Coronary Artery Disease.
    Vora AN; Wang TY; Hellkamp AS; Thomas L; Henry TD; Goyal A; Roe MT
    Circ Cardiovasc Qual Outcomes; 2016 Sep; 9(5):513-22. PubMed ID: 27601458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction.
    Li JW; Chen YD; Chen WR; You Q; Li B; Zhou H; Zhang Y; Han TW
    Cardiovasc Diabetol; 2017 Jun; 16(1):72. PubMed ID: 28587613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homocysteine is a bystander for ST-segment elevation myocardial infarction: a case-control study.
    Chen CJ; Yang TC; Chang C; Lu SC; Chang PY
    BMC Cardiovasc Disord; 2018 Feb; 18(1):33. PubMed ID: 29433446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Long Noncoding RNA LIPCAR Acts as a Novel Biomarker in Patients with ST-Segment Elevation Myocardial Infarction.
    Li M; Wang YF; Yang XC; Xu L; Li WM; Xia K; Zhang DP; Wu RN; Gan T
    Med Sci Monit; 2018 Jul; 24():5064-5070. PubMed ID: 30030914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of bioavailability and antiplatelet action of ticagrelor in patients with ST-elevation myocardial infarction and non-ST-elevation myocardial infarction: A prospective, observational, single-centre study.
    Adamski P; Sikora J; Laskowska E; Buszko K; Ostrowska M; Umińska JM; Sikora A; Skibińska N; Sobczak P; Adamska U; Rość D; Kubica A; Paciorek P; Marszałł MP; Navarese EP; Gorog DA; Kubica J
    PLoS One; 2017; 12(10):e0186013. PubMed ID: 29023473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Myocardial Infarction: Changes in Patient Characteristics, Management, and 6-Month Outcomes Over a Period of 20 Years in the FAST-MI Program (French Registry of Acute ST-Elevation or Non-ST-Elevation Myocardial Infarction) 1995 to 2015.
    Puymirat E; Simon T; Cayla G; Cottin Y; Elbaz M; Coste P; Lemesle G; Motreff P; Popovic B; Khalife K; Labèque JN; Perret T; Le Ray C; Orion L; Jouve B; Blanchard D; Peycher P; Silvain J; Steg PG; Goldstein P; Guéret P; Belle L; Aissaoui N; Ferrières J; Schiele F; Danchin N;
    Circulation; 2017 Nov; 136(20):1908-1919. PubMed ID: 28844989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment and diagnostic relevance of novel serum biomarkers for early decision of ST-elevation myocardial infarction.
    Park HJ; Noh JH; Eun JW; Koh YS; Seo SM; Park WS; Lee JY; Chang K; Seung KB; Kim PJ; Nam SW
    Oncotarget; 2015 May; 6(15):12970-83. PubMed ID: 26025919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Plasma Metabolomics Identify 9-cis-retinoic Acid and Dehydrophytosphingosine Levels as Novel biomarkers for Early Ventricular Fibrillation after ST-elevated Myocardial Infarction.
    Luo J; Shaikh JA; Huang L; Zhang L; Iqbal S; Wang Y; Liu B; Zhou Q; Ajmal A; Rizvi M; Ajmal M; Liu Y
    Bioengineered; 2022 Feb; 13(2):3334-3350. PubMed ID: 35094641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-37 increased in patients with acute coronary syndrome and associated with a worse clinical outcome after ST-segment elevation acute myocardial infarction.
    Liu K; Tang Q; Zhu X; Yang X
    Clin Chim Acta; 2017 May; 468():140-144. PubMed ID: 28237549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.